Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 21.2B | 19.6B | 20.0B | 17.0B |
Cost of revenue | 8.9B | 7.8B | 7.9B | 6.7B |
Gross profit | 12.2B | 11.8B | 12.1B | 10.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 4.6B | 4.5B | 4.8B | -3.7B |
Operating income | 2.9B | 2.6B | 2.8B | 2.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 390.3M | 317.8M | 462.2M | 571.1M |
Other income expense | — | — | — | — |
Pretax income | 2.6B | 2.3B | 2.7B | 1.7B |
Tax provision | 633.8M | 738.3M | 718.6M | 458.9M |
Net income | 2.0B | 1.6B | 2.0B | 1.2B |
Basic EPS | — | 8.1 | 10.3 | — |
Diluted EPS | — | 8.1 | 10.3 | — |
Basic average shares | — | 189.3M | 188.4M | — |
Diluted average shares | — | 189.3M | 188.4M | — |
EBITDA | 4.1B | 3.6B | 4.2B | 3.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | -82.8M | -23.7M | -69.8M | -58.5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |